Serum hepcidin-20 is elevated during the acute phase of myocardial infarction

Tohoku Journal of Experimental Medicine

Volumn 218, Issue 2, 2009, Pages 93-98

  Suzuki, Hiroshi ^a   Toba, Ken ^b   Kato, Kiminori ^b   Ozawa, Takuya ^b   Tomosugi, Naohisa ^c   Higuchi, Masato ^c   Kusuyama, Taro ^a   Iso, Yoshitaka ^a   Kobayashi, Naohiko ^d   Yokoyama, Sin Ichiro ^e   Fukuda, Noboru ^e   Saitoh, Hideki ^f   Akazawa, Kohei ^b   Aizawa, Yoshifusa ^b  

^a SHOWA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NIIGATA UNIVERSITY MEDICAL AND DENTAL HOSPITAL   (Japan)

^c KANAZAWA MEDICAL UNIVERSITY   (Japan)

^d DOKKYO MEDICAL UNIVERSITY   (Japan)

^e NIHON UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^f CHUGAI PHARMACEUTICAL CO LTD   (Japan)

Author keywords

Hepcidin; Hepcidin 20; Iron metabolism; Myocardial; Proteomics

Indexed keywords

C REACTIVE PROTEIN; CREATINE KINASE; ERYTHROPOIETIN; HEPCIDIN; HEPCIDIN 20; HEPCIDIN 25; INTERLEUKIN 6; RECOMBINANT ERYTHROPOIETIN; UNCLASSIFIED DRUG; ANTIMICROBIAL CATIONIC PEPTIDE; BIOLOGICAL MARKER; HEPCIDIN (6 25), HUMAN; HEPCIDIN (6-25), HUMAN; INSULIN; PEPTIDE FRAGMENT;

ACUTE HEART INFARCTION; ADULT; AGED; AMINO ACID SEQUENCE; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HUMAN; MALE; PERCUTANEOUS CORONARY INTERVENTION; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RANDOMIZED CONTROLLED TRIAL; SEQUENCE HOMOLOGY; SURFACE ENHANCED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; ACUTE DISEASE; BLOOD; CHEMISTRY; HEART INFARCTION; INFLAMMATION; METABOLISM; MIDDLE AGED; MOLECULAR GENETICS; TIME;

ACUTE DISEASE; ADULT; AGED; AMINO ACID SEQUENCE; ANTIMICROBIAL CATIONIC PEPTIDES; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CREATINE KINASE; ERYTHROPOIETIN; FEMALE; HUMANS; INFLAMMATION; INSULIN; INTERLEUKIN-6; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; MYOCARDIAL INFARCTION; PEPTIDE FRAGMENTS; SEQUENCE HOMOLOGY, AMINO ACID; TIME FACTORS;

EID: 68549085523     PISSN: 00408727     EISSN: 13493329     Source Type: Journal    
DOI: 10.1620/tjem.218.93     Document Type: Article

References (23)

1. Abboud, S. & Haile, D.J. (2000) A novel mammalian iron-regulated protein involved in intracellular iron metabolism. J. Biol. Chem., 275, 19906-19912.
2. Andrews, N.C. (2004) Anemia of inflammation: the cytokine-hepcidin link. J. Clin. Invest., 113, 1251-1253.
3. Donovan, A., Brownlie, A., Zhou, Y., Shepard, J., Pratt, S.J., Moynihan, J., Paw, B.H., Drejer, A., Barut, B., Zapata, A., Law, T.C., Brugnara, C., Lux, S.E., Pinkus, G.S., Pinkus, J.L., Kingsley, P.D., Palis, J., Fleming, M.D., Andrews, N.C. & Zon, L.I. (2000) Positional cloning of zebrafish ferroportin1 identifies a conserved vertebrate iron exporter. Nature, 403, 776-781.
4. Ganz, T. (2003) Hepcidin, a key regulator of iron metabolism and mediator of anemia of inflammation. Blood, 102, 783-788.
5. Hunter, H.N., Fulton, D.B., Ganz, T. & Vogel, H.J. (2002) The solution structure of human hepcidin, a peptide hormone with antimicrobial activity that is involved in iron uptake and hereditary hemochromatosis. J. Biol. Chem., 277, 37597-37603.
6. Kawabata, H., Tomosugi, N., Kanda, J., Tanaka, Y., Yoshizaki, K. & Uchiyama, T. (2007) Anti-interleukin 6 receptor antibody tocilizumab reduces the level of serum hepcidin in patients with multicentric Castleman's disease. Haematologica, 92, 857-858.
7. Krause, A., Neitz, S., Magert, H.J., Schulz, A., Forssmann, W.G., Schulz-Knappe, P. & Adermann, K. (2000) LEAP-1, a novel highly disulfide-bonded human peptide, exhibits antimicrobial activity. FEBS Lett., 480, 147-150.
8. Lee, P., Peng, H., Gelbart, T., Wang, L. & Beutler, E. (2005) Regulation of hepcidin transcription by interleukin-1 and interleukin-6. Proc. Natl. Acad. Sci U.S.A., 102, 1906-1910.
9. Melino, S., Garlando, L., Patamia, M., Paci, M. & Petruzzelli, R. (2005) A metal-binding site is present in the amino terminal region of the bioactive iron regulator hepcidin-25. J. Pept. Res., 66, 65-71.
10. Merle, U., Fein, E., Gehrke, S.G., Stremmel, W. & Kulaksiz, H. (2007) The iron regulatory peptide hepcidin is expressed in the heart and regulated by hypoxia and inflammation. Endocrinology, 148, 2663-2668.
11. Nemeth, E., Valore, E.V., Territo, M., Schiller, G., Lichtenstein, A. & Ganz, T. (2003) Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein. Blood, 101, 2461-2463.
12. Nemeth, E., Rivera, S., Gabayan, V., Keller, C., Taudorf, S., Pedersen, B.K. & Ganz, T. (2004) IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. J. Clin. Invest., 113, 1271-1276.
13. Nicolas, G., Chauvet, C., Viatte, L., Danan, J.L., Bigard, X., Devaux, I., Beaumont, C., Kahn, A. & Vaulont, S. (2002) The gene encoding the iron regulatory peptide hepcidin is regulated by anemia, hypoxia, and inflammation. J. Clin. Invest., 110, 1037-1044.
14. Park, C.H., Valore, E.V., Waring, A.J. & Ganz, T. (2001) Hepcidin, a urinary antimicrobial peptide synthesized in the liver. J. Biol. Chem., 276, 7806-7810.
15. Rivera, S., Nemeth, E., Gabayan, V., Lopez, M.A., Farshidi, D. & Ganz, T. (2005) Synthetic hepcidin causes rapid dose-dependent hypoferremia and is concentrated in ferroportin-containing organs. Blood, 106, 2196-2199.
16. Rockwell, N.C. & Thorner, J.W. (2004) The kindest cuts of all: crystal structures of Kex2 and furin reveal secrets of precursor processing. Trends Biochem. Sci., 29, 80-87.
17. Roetto, A., Papanikolaou, G., Politou, M., Alberti, F., Girelli, D., Christakis, J., Loukopoulos, D. & Camaschella, C. (2003) Mutant antimicrobial peptide hepcidin is associated with severe juvenile hemochromatosis. Nat. Genet., 33, 21-22.
18. Suzuki, H., Kato, K., Ozawa, T., Toba, K., Akutsu, Y., Iso, Y., Kobayashi, Y., Takeyama, Y., Kobayashi, N., Yokoyama, S., Fukuda, N., Akazawa, K. & Aizawa, Y. (2009) Evaluation of the prospective observation of erythropoietin-administration for the treatment of acute myocardial infarction (EPO-AMI). Circ. J., 73, Supplement I, 126.
19. Tomosugi, N., Kawabata, H., Wakatabe, R., Higuchi, M., Yamaya, H., Umehara, H. & Ishikawa, I. (2006) Detection of serum hepcidin in renal failure and inflammation by using ProteinChip System. Blood, 108, 1381-1387.
20. Turoczi, T., Jun, L., Cordis, G., Morris, J.E., Maulik, N., Stevens, R.G. & Das, D.K. (2003) HFE mutation and dietary iron content interact to increase ischemia/reperfusion injury of the heart in mice. Circ. Res., 92, 1240-1246.
21. Valore, E.V. & Ganz, T. (2008) Posttranslational processing of hepcidin in human hepatocytes is mediated by the prohormone convertase furin. Blood Cells Mol. Dis., 40, 132-138.
22. Vollenweider, F., Kaufmann, J., Irminger, J.C. & Halban, P.A. (1995) Processing of proinsulin by furin, PC2, and PC3 in (co) transfected COS (monkey kidney) cells. Diabetes, 44, 1075-1080.
23. Weiss, G. & Goodnough, L.T. (2005) Anemia of chronic disease. N. Engl. J. Med., 352, 1011-1023.